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ABSTRACT
Mitochondrial transcription factor A (TFAM) is
an abundant mitochondrial protein of the HMG
superfamily, with various putative roles in mito-
chondrial DNA (mtDNA) metabolism. In this study
we have investigated the effects on mtDNA replica-
tion of manipulating TFAM expression in cultured
human cells. Mammalian mtDNA replication inter-
mediates (RIs) fall into two classes, whose mecha-
nistic relationship is not properly understood.
One class is characterized by extensive RNA incor-
poration on the lagging strand, whereas the other
has the structure of products of conventional,
strand-coupled replication. TFAM overexpression
increased the overall abundance of RIs and
shifted them substantially towards those of the
conventional, strand-coupled type. The shift was
most pronounced in the rDNA region and at various
replication pause sites and was accompanied by
a drop in the relative amount of replication-
termination intermediates, a substantial reduction
in mitochondrial transcripts, mtDNA decatenation
and progressive copy number depletion. TFAM
overexpression could be partially phenocopied by
treatment of cells with dideoxycytidine, suggesting
that its effects are partially attributable to a decrea-
sed rate of fork progression. TFAM knockdown
also resulted in mtDNA depletion, but RIs remained
mainly of the ribosubstituted type, although termi-
nation intermediates were enhanced. We propose
that TFAM influences the mode of mtDNA replica-
tion via its combined effects on different aspects of
mtDNA metabolism.
INTRODUCTION
In mammalian cells, mitochondrial DNA (mtDNA) was
long believed to replicate by an unusual, strand-asymmetric
mechanism (1). However, recent studies, using two-
dimensional neutral agarose gel electrophoresis (2DNAGE),
have revealed the presence, both in vertebrate tissues and
cultured cells, of two classes of mtDNA replication inter-
mediates (RIs) whose structures are not consistent with
the strand-asymmetric model. Both classes are essentially
duplex throughout their length, but differ in their ribo-
nucleotide content (2,3). One class shows extensive RNA
incorporation on the lagging strand [ERIOLS, Ref. (2)],
whereas the other has structures fully consistent with
conventional, strand-coupled DNA replication (3–5). ERI-
OLS intermediates are generally nicked or gapped on the
RNA strand (2) and are hence labile to partial degradation
during extraction.
The mechanistic relationship between RIs of the ERIOLS
and strand-coupled types, as well as how they relate to the
‘orthodox’, strand-asymmetric replication model, are not
properly understood. ERIOLS intermediates have been
suggested to be processed to resemble those of the strand-
coupled type via a maturation step (2). Different replication
modes may also operate simultaneously in the same cell. In
solid tissues, strand-coupled replication appears to initiate
bidirectionally in a broad origin zone, spanning at least
several kilobases downstream of the major non-coding region
(NCR) of the genome (5,6). In cultured cells recovering from
drug-induced mtDNA depletion, such initiation is conﬁned to
a much narrower region of the NCR (3). The initiation
mechanism which gives rise to RIs of the ERIOLS type
remains unclear. Initiation within the NCR can also give
rise to the synthesis of 7S DNA (1), which establishes the
characteristic D-loop form of mtDNA, although its relation-
ship with productive replication of the genome remains
enigmatic.
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HMG-box protein of mitochondria, appears to have multiple
functions in mtDNA metabolism (7). It was originally
characterized by the absolute requirement for the protein
for transcriptional initiation in vitro at either the heavy- or
light-strand promoter of the genome (8). More recently,
these ﬁndings were conﬁrmed using a fully reconstituted
system, containing mtDNA-derived templates, RNA poly-
merase and the additional transcription factor TFB1M or
TFB2M (9). Transcription from the light-strand promoter is
required to create the primer for heavy-strand mtDNA
synthesis according to the orthodox, strand-asymmetric
replication model. Therefore TFAM has been considered to
be an essential protein also for mtDNA replication. Consis-
tent with this view, abolition of TFAM expression using a
conditional knockout strategy in the mouse showed clearly
that TFAM is required for mtDNA maintenance as well as
cellular function and survival (10). However, this ﬁnding is
also consistent with TFAM protein having other essential
roles in mtDNA metabolism.
TFAM has been proposed to play a structural role in the
maintenance of the mitochondrial chromosome, independent
of its transcriptional activity. It is highly abundant, is mainly
(or entirely) complexed with mtDNA in nucleoid structures
(11,12), shows signiﬁcant, non sequence-speciﬁc DNA-
binding (8) and promotes DNA compaction (13), leading to
the suggestion that it coats the entire DNA in a manner simi-
lar to histones in the eukaryotic nucleus or the HU protein
in bacteria (14). Its homologue in yeast, Abf2p, has been
shown to induce compaction by introducing sharp bends
into the DNA backbone (15) and is required for the stable
maintenance of wild-type mtDNA (16).
Mammalian TFAM has preference for binding to branched
DNA structures such as Holliday junctions (17) and to
cisplatin-damaged or oxidized DNA (18). In vitro, TFAM
promotes the resolution of D-loop forms (19). It also interacts
physically with p53 [Ref. (20)], suggesting a possible func-
tion in DNA repair or other recombinational processes.
Although it does not have a directly protective role, TFAM
overexpression in rat myoblasts has been reported to acceler-
ate the recovery of mtDNA levels after peroxide damage (21)
and transgenic expression of human TFAM in mice mitigates
mtDNA loss and other mitochondrial defects after cardiac
ischemia (22). In yeast, Abf2p is required for recombination
and segregation of mtDNA to daughter cells (23) and genetic
evidence also implicates it in non-recombinational mtDNA
repair pathways (24). All of these pieces of evidence point
to TFAM and its homologues being key regulators of DNA
transactions in mitochondria.
In organello, TFAM imported into rat liver mitochondria
stimulates the synthesis both of mitochondrial RNAs (25)
and 7S DNA (26). Transient overexpression of TFAM in
cultured HEK cells also results in increased transcription,
but with no change in mtDNA copy number (27). However,
high levels of TFAM added exogenously in vitro (9,28,29), as
well as prolonged over expression in HEKcultured cells (27),
bring about a paradoxical decrease in transcription. This
effect may be attributable to an over-condensed state in
the template DNA. The transient increase in mitochondrial
transcription brought about by TFAM over-expression in
HEK cells is accompanied by an increased level of RNase
H-sensitive mtDNA species (27), which may correspond
with RIs of the ERIOLS type.
Several lines of evidence suggest that TFAM regulates
mtDNA copy number independently of its role(s) in trans-
cription. Heterozygosity for TFAM knockout produces copy
number depletion of  40% in mice (10) and 50% in chicken
cells (30), but with minimal effects on RNA levels. Although
human TFAM has only a weak transcription-stimulatory
effect on mouse mtDNA promoters in vitro, transgenic
expression of human TFAM in mice produces a stoichio-
metric increase in mtDNA levels (31). Overexpression of a
transcriptionally inert variant of TFAM in human cells also
results in a proportionate copy number increase (14), whilst
TFAM knockdown by RNA interference (RNAi) causes
copy number depletion with only minor effects on trans-
cription per template molecule (14). In chicken cells in
which the endogenous c-TFAM gene has been disrupted,
transgenic c-TFAM lacking the C-terminal tail region
required for transcription-promoting activity is nevertheless
able to support maintenance of mtDNA at 50% of wild-
type levels (30).
The idea that TFAM regulates mtDNA copy number by a
simple titration model is, however, contradicted by the obser-
vation that, following transient, ethidium bromide (EtBr)-
induced mtDNA depletion in cultured cells, TFAM levels
were observed to recover more slowly than mtDNA. This
suggests that the packing ratio of TFAM on mtDNA can
vary and may inﬂuence the rate of mtDNA replication (32).
In order to investigate further the effects and mode of
action of TFAM on mtDNA replication and copy number
modulation, we analysed mitochondrial RIs from cells over-
expressing TFAM and from cells in which TFAM expression
was knocked down by RNAi. We report here that overexpres-
sion of TFAM brings about a dramatic change in the
relative abundance of strand-coupled versus ribosubstituted
(ERIOLS-type) RIs, accompanied by systematic alterations
in copy number, transcript levels and mtDNA topology.
In contrast, TFAM knockdown results in copy number
depletion, but with only minimal effects on mtDNA RIs.
The ﬁndings are consistent with the idea that the synthesis
of mtDNA is dependent on at least two different
TFAM-inﬂuenced processes, one of which is transcription-
associated, the other related to mtDNA organization.
MATERIALS AND METHODS
TFAM constructs
Full-length TFAM cDNA lacking its usual stop codon
was ampliﬁed from a cDNA clone (27, kind gift of
Dr R. Wiesner), using the following primers (restriction
sites as indicated, underlined, start codon in bold italics):
50-CCGGAATCCGCGATGGCGTTTCTCCGAAGC-30
(EcoRI) and 50-CGCGGATCCACACTCCTCAGCACCAT-
ATTTTCG-30 (BamHI)
The restriction-digested PCR product was ligated into
EcoRI + BamHI-cut pcDNA3.1( )Myc-HisA (Invitrogen)
to create the construct mtTFA-myc, capable of directing
the expression of C-terminally Myc-His epitope-tagged
TFAM. The full-length TFAM cDNA, including the natural
stop codon, was ampliﬁed using the following primers
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codons in bold italics):
50-CCCAAGCTTGCGATGGCGTTTCTCCGAAGC-30
(HindIII) and 50-CGCGGATCCTTAACACTCCTCAGCAC-
CATATTTTC-30 (BamHI).
The restriction-digested PCR product was ligated into
HindIII + BamHI-cut pcDNA3.1(+) vector, to create the
construct mtTFApcDNA3.1 for transient expression.
In order to create cell lines inducibly expressing either
natural TFAM or C-terminally Myc epitope-tagged TFAM,
the two plasmids described above were digested with PmeI
and the liberated inserts recloned into the vector pcDNA5/
FRT/TO (Invitrogen), which was then transfected into the
Flp-In
TM T-Rex
TM-293 host cell line (Invitrogen) according
the manufacturer’s recommendations. Full details of the
use of this system to create cell lines inducibly expressing
proteins involved in mtDNA metabolism will be published
elsewhere (S. Wanrooij et al., manuscript in preparation).
siRNAs for TFAM knockdown
TFAM siRNAs were synthesized using the Silencer
TM siRNA
construction kit (Ambion). Six putative TFAM-speciﬁc
siRNA sequences were selected using the manufacturer’s
prediction programme (www.ambion.com/techlib/misc/
siRNA_ﬁnder.htlm). After testing by transfection and western
blotting (see below), two were found to be efﬁcient. The
sequences of the relevant mRNA targets were as follows.
Si2: 50-AAGTTGTCCAAAGAAACCTGT-30 (np 273–293
of the TFAM mRNA sequence, Genbank NM_003201) and
Si4: 50-AAGATGCTTATAGGGCGGAGT-30 (np 431–451,
exon 4). See legend to Supplementary Figure 3 for details
of other siRNAs tested in trial experiments.
Cell-culture and transfection
HEK293T and Flp-In
TM T-Rex
TM-293 cells (Invitrogen)
were cultured in DMEM containing 4.5 g/l glucose, 2 mM
L-glutamine, 1 mM sodium pyruvate, 50 mg/ml uridine and
10% fetal bovine serum, at 37 C in a humidiﬁed atmosphere
with 5% CO2 in air. No antibiotics were added for HEK293T
cells, but transgenes in Flp-In
TM T-Rex
TM-293 cells were
maintained under selection with hygromycin and blasticidin
according to the manufacturer’s recommendations. All cell
lines were routinely detached by pipetting alone and passaged
at 1:10 dilution every 3–4 days. TFAM transgene expression
was induced by adding 10 ng/ml doxycyclin (Sigma-Aldrich)
to the culture medium for the times indicated in the
Figures and legends. Transfections were carried out using
TransFectin
TM-lipid reagent (Bio-Rad), following the manu-
facturer’s recommended procedure, with 12 mg of plasmid
DNA and 40 ml of reagent, both in 1.5 ml of serum-free
medium, per 10 ml plate.
For TFAM knockdown, HEK293T cells were transfected
using Lipofectamine
TM 2000 (Invitrogen) and a ﬁnal concentra-
tion of 20 nM of siRNA. To arrest mtDNA synthesis by chain
termination, cells were treated for various times in medium
containing 100 mM dideoxycytidine (Sigma-Aldrich). To
suppress both mtDNA copy number and mitochondrial trans-
cription, cells were treated with medium containing EtBr
(50 ng/ml) for 72, after which cells were washed and replated
in fresh medium, then cultured for a further 48 h.
DNA and RNA extraction and quantitation
For mtDNA copy number analysis, total cellular DNA was
extracted using standard techniques (33). Copy number was
assessed independently by two different methods, to mini-
mize possible artefacts. For Southern blotting, total DNA
was cut by EcoRI and analyzed as described in Ref. (34),
with quantitation by phosphorimaging (Storm 840 scanner
and ImageQuant 5.1 software, all from Molecular Dynamics).
Copy number was also estimated by real-time quantitative
PCR (35) with Taqman probes for mitochondrial cytochrome
b and for amyloid precursor protein (APP), used as a single-
copy nuclear DNA standard. Primers and probes were as
follows (all 50–30): APP Forward: TTTTTGTGTGCTCTCC-
CAGGTCT, APP Reverse: TGGTCACTGGTTGGTTGGC,
APP Probe (FAM+BHQ): CCCTGAACTGCAGATCACCA-
ATGTGGTAG, Cyt-b Forward: GCCTGCCTGATCCTCC-
AAAT, Cyt-b Reverse: AAGGTAGCGGATGATTCAGCC,
Cyt-b Probe (TET+BHQ): CACCAGACGCCTCAACC-
GCCTT.
RNA extraction from cells, agarose or urea–PAGE and
Northern hybridization were as described previously
(34,36). Probes were
32P end-labelled oligonucleotide as
follows (50–30): for ND3 mRNA, GTCACTCATAGGCCAG-
ACTT, for 5S rRNA (loading control), GGGTGGTATGGC-
CGTAGAC, for tRNA
Leu(UUR) and tRNA
Tyr as described
previously (37). Quantitation was by phosphorimaging as
for mtDNA copy number.
For the preparation of mtDNA (mitochondrial nucleic
acids) for analysis of RIs, mitochondria were isolated from
cells essentially as described by Spelbrink et al. (38). Brieﬂy,
cells from 10 to 20, 14 cm plates were collected by pipetting
in PBS, centrifugation at 400 gmax for 3 min at room tempera-
ture and transfer to ice. The cell pellet was resuspended by
gentle pipetting in two volumes of ice-cold 0.1· homogeniza-
tion buffer (4 mM Tris–HCl, pH 7.8, 2.5 mM NaCl, 0.5 mM
MgCl2), kept on ice for 5 min and homogenized in a glass
homogenizer with 20 strokes of a tight-ﬁtting pestle. Disrup-
tion of the cells was monitored by microscopy. One-ninth
volume of 10· homogenization buffer was added and nuclei
and cell debris were pelleted by sequential centrifugations at
1200 gmax for 3 min at 4 C until no pellet was visible.
Mitochondria from the post-nuclear supernatants were recov-
ered by centrifugation at 16000 gmax for 10 min at 4 C.
The mitochondrial pellet was washed once in resuspension
buffer (10 mM Tris–HCl pH 7.4, 0.32 M sucrose, 1 mM
EDTA, 5 mM MgCl2) and re-centrifuged at 16000 gmax for
10 min at 4 C. The pellet was placed immediately on ice
and resuspended thoroughly in 500 ml of DNA extraction
buffer (25 mM EDTA pH 8.0, 75 mM NaCl) followed by
the addition of 50 ml 10% SDS with gentle mixing and
incubation on ice for a further 10 min. An equal volume
of phenol:chloroform:isoamyl alcohol (25:24:1, pH 8,0) was
added and the tube was shaken gently overnight at 4 Co na
rotatory shaker, then centrifuged at 5000 gmax for 15 min at
4 C. The aqueous phase was transferred to a fresh tube and
phenol extraction repeated several times until the interface
was clear, after which 0.2 vol. 10 M ammonium acetate
and 2 vol. 80% EtOH were added to the ﬁnal aqueous
phase. The solution was gently mixed, incubated on ice for
15 min and centrifuged at 5000 gmax for 15 min at 4 C.
The precipitated nucleic acids were washed once with 80%
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pellet was air- dried, dissolved in 80 ml of TE buffer and
stored at 4 C.
Enzymatic treatment of DNA
MtDNA samples were treated with the following DNA-
modifying enzymes under conditions recommended by the
manufacturers: T7 gp3 endonuclease (New England Biolabs),
topoisomerase I (New England Biolabs) and topoisomerase
IV (John Innes Enterprises).
Two-dimensional neutral agarose gel electrophoresis
One microgram of total mitochondrial nucleic acids was used
per analysis. Restriction digestions were performed following
manufacturers’ recommendations, except for BclI which
was carried out at 37 C for double the usual reaction time.
If subsequent nuclease treatments were used, DNA was ﬁrst
recovered by ethanol precipitation and resuspended in the
appropriate reaction buffer, before treatment with 50 U of
RNaseI (New England Biolabs), 2 U of RNaseH (Promega),
each for 1 h at 37 C or 50 U S1 Nuclease (Promega) for 30 s.
Reactions were stopped by the addition of an equal volume of
phenol–chloroform–isoamyl alcohol (25:24:1, pH 8.0) and
immediately extracted. 2DNAGE was performed essentially
as described in Kajander et al. (39). The ﬁrst-dimension
was run without EtBr in a 0.4% agarose gel in TBE buffer,
1.2 V/cm for 24 h at 4 C. The gel was stained with EtBr
(300 ng/ml) in TBE. Individual lanes were cut out, rotated
90  and 1.0% agarose containing 300 ng/ml EtBr, precooled
to 55 C, was cast around them. The second dimension was
run at 6 V/cm for 5 h at 4 C with constant buffer recircu-
lation. For analysis of high molecular weight fragments
(e.g. 16.6 kb mtDNA linears), the ﬁrst-dimension gels were
0.28% agarose, run at 1.4 V/cm for 24 h at room temperature,
with the second dimension in 0.58% agarose, 300 ng/ml EtBr,
run at 2.6 V/cm for 67 h at room temperature with constant
buffer recirculation. Gels were processed for Southern
blotting using standard procedures.
Radiolabelled probes and blot hybridization
For Southern hybridization, the following probes were
created by Pfu-PCR, using cloned segments of human
mtDNA as template and subsequently sequenced to
conﬁrm their identity: OH (np 35–611, Anderson et al.,
1981), ND2 (np 4480–4988), A8-6 (np 8460–9107), ND4
(np 11161–11640) and ND5 (np 12992–13670).
Probes were labelled using Rediprime
TM II random prime
labelling kit (Amersham) and [a-
32P]dCTP (Amersham;
3000 Ci/mmol).
Sub-fractionation of mitochondria
For assaying the localization of recombinant TFAM the
mitochondrial pellet, prepared as above, was resuspended in
2 vol. of lysis buffer (0.25 M sucrose, 20 mM Tris–HCl,
pH 7.6, 2 mM EDTA, 7 mM b-mercaptoethanol). Mitochon-
dria were lysed by adding 20% NP40 to a ﬁnal concentration
of 0.5% (v/v) with incubation on ice for 1 h. After centri-
fugation at 16000 gmax for 10 min at 4 C the pellet and
supernatant fractions were processed for SDS–PAGE.
SDS–PAGE and western blotting
SDS–PAGE used 7.5–12% polyacrylamide (Laemmli) gels
under standard conditions. Sample preparation, western
blotting and immunodetection were carried out as described
previously (38). Primary antibodies used were: mouse anti-
Myc monoclonal 9E10 (Roche Molecular Biochemicals),
1:15000 dilution of a 5 mg/ml stock, rabbit anti-human
TFAM (kind gift of Dr R. J. Wiesner), 1:10000 dilution
and mouse anti-a-actinin monoclonal AT6/172 (Upstate)
1:5000 of a 1 mg/ml stock. Signals were quantiﬁed using a
ChemiDoc XRS chemiluminescence detection instrument
and associated QuantityOne software.
RESULTS
Effects on mitochondrial nucleic acids of modulating
TFAM expression levels in vivo
We manipulated TFAM expression levels in cultured human
cells using transient or inducible expression of epitope-tagged
or untagged TFAM, as well as TFAM knockdown by RNAi
(Figure 1, see also Supplementary Figures 1–3). Transient
expression (data not shown) produced essentially the same
effects on all parameters studied as inducible over-expression
using the Flp-In  T-Rex system, although with less quanti-
tative reproducibility. Inducible over-expression of TFAM
carrying a C-terminal MycHis tag produced qualitatively
similar but quantitatively more dramatic effects, namely
a small but transient increase in mtDNA copy number,
followed by progressive mtDNA depletion. After 10 days
of full induction (10 ng/ml doxycyclin, full details on the
use of the induction system to be published elsewhere,
Wanrooij et al., manuscript in preparation), TFAM-MycHis
expression resulted in the reduction of mtDNA levels to
 20% of control levels. Over-expression of TFAM with its
normal stop codon (TFAM-stop) caused a decrease in
mtDNA copy number of 40–60%. Copy number depletion
was veriﬁed by two independent methods, real-time PCR
and phosphorimaging of Southern blots (Supplementary
Figures 1 and 2).
Although the absolute amount of TFAM protein did not
increase markedly during induction, measured relative to a
loading control (Supplementary Figures 1 and 2), the progres-
sive drop in mtDNA copy number means that the amount of
TFAM protein per mtDNA molecule did increase substan-
tially and consistently during induction: in the case of
TFAM-stop to over twice the endogenous level, in the case
of TFAM-MycHis by an order of magnitude. Crude fractiona-
tion of mitochondrial protein lysates by sucrose density-
gradient centrifugation (Supplementary Figure 2) showed
that over-expressed TFAM-MycHis partitioned, like endo-
genous TFAM, mainly into the pellet fraction, forming
high-molecular weight complexes in the same proportion as
endogenous TFAM, indicating that it is likely complexed
with mtDNA.
Previous experiments in vitro and in organello have
suggested that a large excess of TFAM can suppress rather
than activate transcription. We measured the steady-state
levels of various mitochondrial transcripts using northern
blot analysis (Supplementary Figures 1 and 2 and other
5818 Nucleic Acids Research, 2006, Vol. 34, No. 20data not shown), under conditions where over-expression
of TFAM-stop or TFAM-MycHis was induced in vivo.
The level of short-lived mRNAs such as ND3 showed a
marked decline even relative to the decreased amount
of mtDNA. Although modulation of post-transcriptional
processing and RNA stability contribute to changes in the
steady-state level even of short-lived transcripts, the drop in
ND3 mRNA levels is consistent with a substantial drop in
transcription per template molecule, under conditions of
TFAM over-expression, which was especially marked for
TFAM carrying the C-terminal MycHis tag. As a more
rigorous and direct test of its effects on transcriptional activ-
ity, we also analysed the consequences of TFAM-MycHis
expression on the rate of recovery in mitochondrial tRNA
levels in cells treated for 72 h with EtBr, following removal
of the drug (Supplementary Figure 4).
In conformity with the published literature, RNAi knock-
down of TFAM produced a progressive reduction of TFAM
protein levels and mtDNA copy number. A combination of
two siRNAs was selected, based on preliminary trials,
which decreased TFAM protein to low levels (<10%) during
7 or 14 days continuous culture (Supplementary Figure 3).
Over shorter-time periods, both TFAM protein and mtDNA
depletion by RNAi were rather modest and the levels of
TFAM protein or ND3 mRNA per template mtDNA molecule
were almost unchanged from control cells (Figure 1).
Altered TFAM expression leads to systematic effects on
mtDNA replication intermediates
The copy number depletion of mtDNA produced either
by RNAi knockdown or by over-expression prompted us
to investigate further the effects of these treatments on
mtDNA replication, using 2DNAGE. Transient expression
of TFAM-stop or inducible overexpression of either TFAM-
stop or TFAM-MycHis, produced dramatic and systematic
effects on the patterns of mtDNA RIs, which were essentially
the same in all three cases (Supplementary Figure 5b). The
most consistent effects on RIs were seen after 48 h of induced
over-expression (or 48 h after transient transfection), when
effects on mitochondrial transcripts were clearly evident
and quite similar in all cases.
TFAM overexpression resulted in a substantially increased
abundance of RIs relative to the unit-length restriction
fragment (Figure 2; see Supplementary Figure 5 for further
explanations and interpretations of the gel data). For example,
Figure 1. Effects of induced expression of TFAM-stop and TFAM-MycHis and of RNAi knockdown of TFAM expression. Mitochondrial proteins, DNA and
RNA were analysed from Flp-In
TM T-Rex
TM -293 cells stably transfected with the TFAM-stop (a–c) or TFAM-MycHis construct (d–f), induced over the times
indicated or from HEK293T cells (g–i) following transfection with siRNAs Si2 and Si4 over the times indicated. In each case, error bars indicate means ± SEs
from at least three independent experiments. a.u., arbitrary units. Measurements of mtDNA levels (a, d and g) are arbitrarily normalized to the mean values for
uninduced or untreated cells. For cells under TFAM induction, the measurements were made by two independent methods, Southern blotting and Q-PCR and the
values plotted for each time point are the means of measurements by the two methods, shown in Supplementary Figures 1 and 2. (b, e and h) show TFAM protein
levels normalized to the mtDNA levels shown in (a, d and g), then normalized against the level in uninduced or untreated cells. (c, f and i) show ND3 mRNA
levels normalized first against the 5S rRNA loading control, then against the mtDNA levels shown in (a, d and g), then finally against the level in uninduced or
untreated cells. Samples of the raw data and compiled data for TFAM protein, mtDNA and RNA levels on which this figure is based, are shown in Supplementary
Figures 1–3.
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ome (PvuII, np 2560, Figure 2b), TFAM over-expression
gave a clear enhancement of the clubheaded bubble arc
indicative of initiation far upstream of the restriction site,
as well as revealing a prominent simple Y-arc. In uninduced
cells these RIs were either much fainter or absent. The main
features were the clubheaded bubble arc and corresponding
double-Y arc, as well as a number of species that were
sensitive to or modiﬁed by, RNaseI treatment. The RNaseI-
sensitive species included circular molecules, a short arc
which corresponds with dimeric circles and/or broken theta
forms (T. Yasukawa, personal communication), plus a diffuse
cloud of material migrating in the region between circular
molecules and the bubble arc. A putative termination arc
was also visible only in uninduced cells, although this was
revealed more clearly when other species were modiﬁed by
RNaseI (Supplementary Figure 5).
In other digests, the exact transformations of RIs resulting
from TFAM overexpression varied according to which region
of the genome was being analysed (Figure 2c–e). In general,
ERIOLS-type RIs, i.e. slow-moving arcs and ‘clouds’ of hete-
rogeneous, nuclease-sensitive material were diminished and
migrated as more discrete entities. There was general
enhancement of nuclease-resistant arcs, in particular those
resistant to S1 nuclease. In addition, rather speciﬁc sub-
types of RIs were seen to accumulate along the arcs, which
differed from those seen in uninduced or untransfected cells.
Changes were most dramatic in the rDNA region, extend-
ing to OL (Figure 2d). In uninduced cells, in contrast to the
patterns of RIs from this region of the genome seen in solid
tissues or in cultured cells recovering from drug-induced
mtDNA depletion (2–4), complete Y-arcs of the strand-
coupled type were not detectable, even on long exposure.
Instead, a heterogeneous ‘cloud’ of complex, high-molecular
weight material was seen, plus the ascending portion of a
Y-like arc, ending in a faintly detected replication pause
site within the ND1 gene. These forms were partially sensi-
tive to or modiﬁed by nucleases. In TFAM overexpressing
cells, a complete Y-arc was easily detected, even at relatively
low exposure. The descending portion of this arc was now the
most prominent, although this segment was relatively sensi-
tive to nucleases. The cloud of heterogeneous material was
replaced by at least two discrete, slow-moving Y-like arcs,
which were also nuclease-sensitive. The replication pause
Figure 2. 2DNAGE analysis of mtDNA replication intermediates (RIs) in cells induced to overexpress TFAM-stop. (a) Diagrammatic map of human mtDNA,
showing the origins of heavy- (OH) and light-strand (OL) replication according to the orthodox model, relevant restriction sites and probes for the three regions of
the genome analysed (approximate location of probes indicated by asterisks). NCR shown as dark grey bar, rDNA as pale grey bar. (b–e) 2DNAGE of mtDNA
from uninduced cells and from cells induced to express TFAM-stop for 48 h, analysed using the restriction digests and probes indicated, with or without
additional enzymatic treatments as shown. In each panel, the various arcs and other salient features are denoted as follows: Y, standard Y arcs, dY, standard
doubleY arcs, c, ‘cloud’ of RNase-sensitive material, o, circular molecules, b, standard bubble arcs, s, slow-moving Y-like arcs, sensitive to various nucleases, t,
termination intermediates lying on a portion of a standard X arc, p, prominent pause sites. See Supplementary Figure 5 for diagrammatic interpretations of the
various arcs. Panels i and iv of part (b) and panels iii and iv of part (c) are equivalent exposures, for comparison. Other panels of uninduced cell mtDNA are 5- to
10-fold more exposed than induced cell material, in order to reveal the main features of the arcs. Note the general enhancement of RIs, relative loss of nuclease-
sensitive species, of termination intermediates and of bubble arcs, following TFAM induction. The appearance of a complete or almost complete, Y arc in
Figure 2b, panels iv–vi, is consistent with frequent strand breakage at OH or with recombinational strand-switching (also generating a free end at OH) or with
frequent initiation far distant from the NCR.
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treatment.
The major NCR (Figure 2c), containing the principal sites
of replication initiation and termination, showed more subtle
changes, affecting most obviously the termination region. In
uninduced cells, the most prominent species were termination
intermediates lying on or close to the apex of the X-arc, plus
a heterogeneous cloud of material migrating at high mole-
cular weight which, after nuclease treatment, was either
modiﬁed (RNaseI or H) or abolished (S1). The ascending
portion was the most prominent portion of the partial Y arc
and this was also sensitive to ribonucleases, as was the bubble
arc. In TFAM overexpressing cells the bubble arc was barely
visible even on long exposure and the descending portion of
the partial Y arc, leading to the termination site, was strongly
enhanced. However, termination intermediates lying on the
X-arc were less prominent, especially after S1 nuclease treat-
ment. Heterogeneous, high molecular weight, S1-sensitive
material was less dispersed and its migration less affected
by ribonucleases.
We next analysed the nature of fully double-stranded
(i.e. S1 nuclease-resistant) RIs around the genome in further
detail, under conditions of TFAM overexpression (Figure 3).
Different restriction digests (Figure 3b) conﬁrmed that TFAM
overexpression led to an accumulation of material on the
standard Y arc in the region approaching the terminus at
OH, with a corresponding loss of termination intermediates
in which the fork had entered the fragment from the other
end and stalled at the terminus prior to resolution.
A number of pause sites or regions were strongly
enhanced, in addition to the strong pause in ND1
(Figure 3d). These included the pause at OL (Figure 3d),
several discrete sites in the regions of ND4, ND3, COXIII,
A6 and A8, most of the COXII gene (Figure 3c) and a
broad region of the ND5 gene (Figure 2c). Conversely,
the abundance of 7S DNA was diminished by TFAM
overexpression (Figure 6).
RNAi knockdown of TFAM expression produced more
subtle effects on RIs (Figure 4). RIs resistant to S1 nuclease
were little altered (Figure 4c), but ribonuclease-sensitive
‘clouds’ of heterogeneous, nuclease-sensitive material were
somewhat enhanced, especially in the rDNA region
(Figure 4c) or showed altered mobility. The clearest
transformation was seen in the origin/termination region
encompassing OH, where there was an increase in the
abundance of double-Y termination intermediates lying on
the X-arc, relative to the bubble and partial Y arcs
(Figure 4b), an opposite result to that produced from
TFAM overexpression, which diminished the abundance of
termination intermediates (Figures 2 and 3).
Figure 3. 2DNAGE analysis of S1 nuclease-resistant mtDNA RIs in cells induced to overexpress TFAM-stop. (a) Diagrammatic map of human mtDNA,
nomenclature as for Figure 2a. (b–d) 2DNAGE of mtDNA from uninduced cells and from cells induced to express TFAM-stop for 48 h, analysed using the
restriction digests and probes indicated. All samples were treated with S1 nuclease before electrophoresis. Nomenclature as for Figure 2, plus pr, pause region
(replication slow-zone). See Supplementary Figure 5 for diagrammatic interpretations. Comparable exposures are shown, to illustrate the general enhancement of
S1-resistant RIs, the strengthening of pause sites and regions and the decrease in termination intermediates. Note that bubble arcs are not visible at these
exposures following S1 nuclease treatment.
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ddC treatment
Arcs of fully double-stranded, ribonuclease-insensitive RIs
should be generated by true strand-coupled replication. How-
ever, they could also arise from maturation of ERIOLS type
intermediates and, if so, should be enhanced where leading-
strand synthesis has stalled randomly or has been drastically
slowed (i.e. if the rate of lagging-strand maturation is now
comparable with that of fork progression). The effects of
TFAM overexpression could thus be interpreted either as a
switch to strand-coupled-type replication or as a general
slowing in progression of the replication fork, such that
maturation of the lagging strand now occurred as fast as the
fork progressed.
To address this issue we compared the effects on mtDNA
RIs of TFAM over-expression with treatment of cells with the
replication inhibitor dideoxycytidine, ddC (Figure 5). After
conversion to ddCTP this drug produces repeated chain
termination events during mtDNA replication, requiring
removal of the incorporated dideoxynucleotide by exonucle-
ase action or recombination, thus greatly slowing down the
overall rate of fork progression and leading to mtDNA deple-
tion. As shown in Figure 5, ddC treatment induced rather
similar transformations in the pattern of mtDNA RIs as
those brought about by TFAM overexpression: progressive
and dramatic reduction in ERIOLS-type RIs, a corresponding
increase in fully double-stranded RIs of the strand-coupled
type (Figure 5d) and the disappearance of termination inter-
mediates (Figure 5b, panels i–iii). Removal of the drug
rapidly induced a burst of mtDNA replication but with inter-
mediates remaining initially of the strand-coupled type and
with a delayed re-appearance of termination intermediates
(Figure 5b, panel vii). However, both during and following
ddCTP treatment, the enhancement of RIs of the strand-
coupled type was more general than that resulting from
enhanced TFAM expression, rather than being concen-
trated in the rDNA region and at replication pause sites
(e.g. compare Figure 5e, panels ii and iii).
Alterations to TFAM expression modify
mtDNA topology
The effects of TFAM overexpression on mtDNA replication
might reﬂect TFAM-induced changes in transcription or
in the overall organization of mtDNA. To test whether
modulation of TFAM expression affects mtDNA topology
or organization, we analysed uncut mtDNA from TFAM-
induced and uninduced cells, both before and after treatment
with various DNA-modifying enzymes (Figure 6). In unin-
duced cells, most of the mtDNA migrated either as relaxed
circles or in high molecular weight catenated forms that
were sensitive to topoisomerase IV but not topoisomerase I.
A pronounced smear of material was also visible in the
high molecular weight region of the gel. Induced TFAM
over-expression resulted in a pronounced shift towards mono-
meric supercoils, with much less catenated mtDNA, includ-
ing the high molecular weight smear, as well as creating
novel junctional forms that were resolved by phage T7 gp3
endonuclease. Despite these differences, the residual products
from combined treatment with topoisomerase IV and T7 gp3
were strikingly similar, when comparing TFAM-induced and
uninduced cells. ddC treatment also resulted in a shift away
from catenated forms in favour of monomeric circles, both
relaxed and supercoiled (Supplementary Figure 6). TFAM
knockdown by RNAi produced more subtle changes in
mtDNA topology (Figure 6), with an increased level of
one particular high molecular weight species (arrowed in
Figure 6) and of linear molecules. The arrowed species
corresponded in mobility with a catenated form which
could be enhanced in control cell mtDNA by treatment
with T7 gp3 endonuclease and thus might represent an
abortive termination product.
Finally, we analysed the effects of various treatments on
the steady-state level of 7S DNA. Both ddC treatment
[(40); Supplementary Figure 6] and TFAM overexpression
(Figure 6b) resulted in a substantial drop in the amount of
7S DNA relative to other forms of mtDNA, whereas TFAM
knockdown resulted in a small increase in 7S DNA
(Figure 6b).
DISCUSSION
In this study we investigated the effects on mtDNA replica-
tion of modulating TFAM expression in cultured human
cells. Sustained over-expression, resulting in a >2-fold
increase in the ratio of TFAM to mtDNA, greatly enhanced
the steady-state levels of RIs of the strand-coupled
type, with corresponding depletion of ribonucleotide-rich,
ERIOLS-type RIs. This was accompanied by decreased
mitochondrial transcription, depletion of 7S DNA and of
replication-termination intermediates, reduced copy number
and decatenation of mtDNA. TFAM knockdown in the
same cell background also produced copy number depletion,
Figure 4. 2DNAGE analysis mtDNA RIs in cells treated with TFAM-specific
siRNAs. (a) Diagrammatic map of human mtDNA, nomenclature as for
Figure 2a. (b) and (c) 2DNAGE of mtDNA from control (or mock-
transfected) cells and from cells treated with TFAM siRNAs for 24 h, using
the restriction digests and probes indicated, with or without additional S1
nuclease treatment as shown. Nomenclature as for Figure 2. See
Supplementary Figure 5 for diagrammatic interpretations. Comparable
exposures are shown, to illustrate the general enhancement of termination
intermediates and of the cloud of nuclease-sensitive material migrating at
high molecular weight.
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systematic effects on transcription and, apart from a strong
enhancement of termination intermediates, virtually no
change in the pattern of RIs. The ﬁndings suggest that
TFAM can inﬂuence mtDNA replication and copy number
in several different ways.
TFAM as a structural protein of the
mitochondrial chromosome
Previous views of TFAM as a copy number regulator have
assumed that the ratio of TFAM:mtDNA is invariant, so
that changes in the rate of TFAM synthesis determine
the amount of mtDNA present in the cell (10,14,30,31).
Figure 5. 2DNAGE analysis of RIs in cells induced to overexpress TFAM-stop or treated with ddC. (a) Diagrammatic map of human mtDNA, nomenclature as
for Figure 2a. (b–e) 2DNAGE of mtDNA from uninduced cells, cells induced to express TFAM-stop for 48 h or HEK293T cells treated with ddC for the
indicated times (72 + 2 h meaning 72 h of treatment followed by 2 h of recovery in fresh medium). Restriction digests and probes as indicated. All samples were
treated with S1 nuclease before electrophoresis. Nomenclature as for Figure 2. See Supplementary Figure 5 for diagrammatic interpretations. Exposure times
vary, as needed to reveal the main features of arcs of RIs. Note the similar effects of TFAM overexpression and ddC treatment: general enhancement of S1
nuclease-resistant RIs, suppression of termination intermediates. Panel vi of part (c) is a longer exposure of panel v.
Figure 6. Effects of TFAM overexpression and knockdown on mtDNA topology. One-dimensional agarose gel blots, hybridized with OH probe. (a) mtDNA
from uninduced cells and from cells induced to overexpress TFAM-stop for 48 h, fractionated on a 0.4% agarose gel run in TBE. Only the high molecular weight
portion of the gel is shown. Samples were either untreated (U) or treated with T7 gp3 endonuclease (gp3), topoisomerase I (tI), topoisomerase IV (tIV) or
topoisomerase IV plus T7 gp3 endonuclease. Identity of the main topoisomers was inferred from enzymatic sensitivity and confirmed by other treatments (data
not shown). DNA from cells treated with TFAM-specific siRNAs (RNAi) for 24 h was run on a separate gel. (b) MtDNA from TFAM-induced, uninduced and
siRNA-treated cells, fractionated on 0.4% agarose gels run in TBE. Only the low molecular weight portion of each gel is shown. First 4 lanes of upper panel are
equally exposed, whereas the right-most two lanes are  3-fold overloaded, to reveal the presence of 7S DNA in induced cells. Samples were either heated for
2 min at 95 C( +) or left unheated, as indicated.
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to mtDNA during mtDNA reampliﬁcation following EtBr
treatment (32) suggests that the TFAM:mtDNA ratio is not
invariant and may indeed be subject to regulation, affecting
mtDNA copy number in ways distinct from a simple titration
model.
The present study offers support to the latter view, by
conﬁrming that an increased ratio of TFAM protein to
mtDNA can be sustained in human cells and has systematic,
but opposite effects on mtDNA copy number than would
be predicted by the simple titration model. Moreover,
whereas most experiments hitherto conducted on TFAM
have employed highly non-physiological tools, such as cells
treated with EtBr, heterologous expression of a human pro-
tein in mice or of a truncated TFAM variant never seen in
nature, we observed alterations in mtDNA replication and
copy number resulting from increased expression of a protein
identical to endogenous TFAM. The fact that we were able to
achieve and sustain an increased ratio of TFAM to mtDNA
contradicts the titration model, but is consistent with the
results of studies using in organello footprinting (41–44),
which indicate that protein binding to mtDNA is not uniform
and thus that there are sites ordinarily unoccupied by protein
where over-expressed TFAM can potentially bind.
The effects of TFAM over-expression on RIs were
qualitatively very similar to those brought about by treatment
with the drug ddC which, following conversion to ddCTP, is
assumed to be a potent inducer of repeated replication stalling
via premature DNA chain termination. ddC treatment
also resulted in a large increase in the steady-state levels of
nuclease-resistant RIs of the strand-coupled type from all
around the mitochondrial genome, with concomitant loss of
termination intermediates. Although the effects of these
treatments were not absolutely identical, with TFAM over-
expression generating a subtly different pattern of such RIs,
especially in the rDNA region and in the vicinity of pause
sites, their overall similarity strongly suggests that the
main effect of TFAM is, like ddC, to provoke a substantial
decrease in the net rate of DNA synthesis. This may
reﬂect an increased compaction of mtDNA when the ratio
of TFAM protein to mtDNA is increased, such that deconden-
sation of the nucleoid becomes rate-limiting for fork progres-
sion. The TFAM-speciﬁc transformations of RIs may reﬂect
different degrees of compaction and inhibition of fork
progression in different regions of the mitochondrial genome,
depending on their afﬁnity for TFAM and other proteins.
The increased abundance of strand-coupled RIs may thus
be due to maturation of ERIOLS-type intermediates, which
we assume normally to be a slow step compared with the
rate of fork progression. If the latter is slowed by increased
compaction, the rate of maturation may become comparable
with it. Alternatively, if the two classes of RI represent
entirely different modes of DNA replication, ERIOLS type
replication might be unable to use a highly compacted
mtDNA template, leaving only strand-coupled replication
(with a less discrete origin, as implied by Figure 2b).
Initiation of bidirectional, strand-coupled replication in
many bacterial plasmids is stimulated by or dependent
on, DNA-bending proteins functionally related to the
HMG superfamily (45). Excess TFAM may thus lead to
copy number depletion by enforcing a switch to an inherently
slower replication mode or simply by suppressing the
alternative mode.
Exactly the same transformations of RIs were produced by
transient expression of TFAM as were produced by inducible
expression of either natural or C-terminally MycHis-tagged
TFAM. However, the two inducible variants brought about
copy number depletion with markedly different kinetics
(Figure 1). Copy number depletion may thus not be due
entirely to a change in the rate of fork progression, but
involve also another TFAM-related process with which the
C-terminal tag may interfere. Such an effect could, however,
be indirect. The amount of TFAM-MycHis protein rose much
more steeply than TFAM-stop during induction (Figure 1,
Supplementary Figures 1 and 2), suggesting that it may
escape physiological turnover mechanisms. This is supported
by the observation (Supplementary Figure 2) that TFAM-
MycHis almost completely replaced endogenous TFAM
during induction. The fact that sustained overexpression of
natural TFAM is comparatively difﬁcult to achieve may
reﬂect a natural homeostatic mechanism, whereby TFAM
levels can modulate copy number only within certain limits.
Another possibility is that, as for other HMG proteins (46),
the C-terminal tail of TFAM recruits or interacts with other
nucleoid proteins. It is already implicated in interactions
with speciﬁc components of the transcriptional apparatus
(47). The epitope tag may therefore disturb interactions
with other nucleoid proteins involved in copy number home-
ostasis. Copy number derangement produced in cells or mice
by C-terminally truncated or heterologous TFAM variants
(14,30,31) may prove to be due to loss of such regulation,
rather than by the titration model inferred previously.
The fact that RNAi knockdown of TFAM results in copy
number depletion without substantial changes in the patterns
of RIs is further evidence that at least one other TFAM-
dependent process is critical for mtDNA maintenance. One
obvious possibility already mentioned is the compaction of
nascent mtDNA into TFAM-containing nucleoid structures,
in the absence of which the newly replicated mtDNA may
simply be unstable. Other possibilities are discussed below.
TFAM as a regulator of mitochondrial transcription
Although TFAM was originally identiﬁed and named on the
basis of its being essential for mtDNA transcription, previous
studies have shown that excess TFAM, supplied either to a
reconstituted in vitro system (9) or produced by sustained
overexpression in HEKcultured cells (27), results in a para-
doxical suppression of transcription. Our own observations
are consistent with this (Figure 1, Supplementary Figures 1
and 2).
A drop in transcriptional activity could, conceivably,
underlie the switch in DNA replication mode that favours
the generation of strand-coupled RIs. Although the decrease
in transcriptional activity which accompanies TFAM overex-
pression appears modest, according to the data of Figure 1
(Supplementary Figures 1 and 2), the steady-state level of
ND3 mRNA is a relatively insensitive measure of the actual
transcription rate. The mechanism by which ERIOLS-type
RIs are generated remains unknown. However, since on
2DNAGE they include heterogeneous ‘clouds’ of material
sensitive to both RNaseI and RNaseH which are suppressed
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they could arise by a mechanism involving either
preformed RNA or nascent transcripts. Transcriptional
suppression by excess TFAM, rather than over-compaction
of the nucleoid, may therefore be the mechanism driving
replication towards the slower, strand-coupled mode. In
support of this, the segment of the genome most affected
by TFAM overexpression is also the most heavily transcribed
region (rDNA), in which discrete RIs are ordinarily hard
to detect (Figure 2d), but became prominent when TFAM
was overexpressed.
Whereas copy number depletion brought about by TFAM
overexpression was accompanied by a clear drop in transcrip-
tion, transcription per template molecule appeared unchanged
when copy number was depleted by TFAM knockdown.
Copy number regulation may therefore be independent of
transcription. However, transcription was more severely
affected by overexpression of epitope-tagged TFAM than
natural TFAM and also provoked a more rapid drop in
mtDNA copy number. The issue of a relationship between
the transcriptional activity of TFAM and copy number con-
trol thus remains open.
TFAM overexpression leads to reduced levels of
7S DNA, which might reﬂect decreased transcriptional
activity at the light-strand promoter and/or enhanced resolu-
tion of D-loop forms in vivo, another known property of
TFAM [(19), see also following section]. If D-loops represent
a precursor step in DNA replication, as proposed by the
orthodox model, their depletion by TFAM overexpression
may be crucial in bringing about copy number reduction
or in inducing a switch to strand-coupled replication. On
the other hand, the increased level of 7S DNA resulting
from TFAM knockdown shows clearly that the D-loop form
is not sufﬁcient to maintain a high copy number.
TFAM as an enhancer of replication pausing
Replication pauses are well documented in both bacteria
and eukaryotes, as well as in plasmids and mtDNA (4,48).
However, their roles in DNA homeostasis are unclear,
except where they function as deﬁnitive terminators. In
human mtDNA, prominent pauses occur at the so-called
termination-associated site delimiting 7S DNA, at OL and
in the region immediately downstream of rDNA, within the
ND1 gene (Figures 2 and 3). One possibility is that, as in
yeast rDNA, these pauses are the signatures of proteins
which bind at speciﬁc sites to facilitate the passage of
oppositely moving replication and transcription complexes
(49) or simply markers of collision sites, as in bacteria
(50), at which replication ﬁnally resumes after dissociation
of the transcriptional machinery (51). Although TFAM has
only a low sequence-speciﬁcity for DNA-binding, it may
enhance such pauses by promoting DNA-bending, as
proposed for the protein Sap1p at one of the replication
pause sites in Schizosaccharomyces pombe rDNA (52).
Such bending may also facilitate the binding of other, more
sequence-speciﬁc DNA-binding proteins, which directly
function in fork arrest. Both copy number depletion and
transcriptional inhibition following TFAM overexpression
may therefore be due, at least in part, to its effect as a strong
enhancer of replication pausing.
TFAM as a cofactor in junctional resolution
TFAM overexpression and TFAM knockdown produced
opposite effects on the abundance of termination interme-
diates. Whereas these were depleted by TFAM overexpres-
sion (or ddC treatment), they were strongly enhanced by
TFAM knockdown (Figures 3–5). A simple interpretation is
that resolution of these forms is a late and slow step in
mtDNA replication, which is in some way dependent on
the supply of TFAM. Under conditions of TFAM overexpres-
sion, either that step is facilitated by increased loading of
TFAM onto the nascent DNA or the rate of fork progression
is slowed down so much that resolution of termination
intermediates is no longer rate-limiting. Under conditions of
TFAM ‘starvation’ this resolution step would conversely be
inhibited and this may be the primary reason for copy number
depletion following TFAM knockdown.
TFAM is already known to have binding preference for
junctional structures (17), to facilitate the resolution of
D-loops (19) and to bend DNA in a manner analogous with
bacterial proteins such as HU and IHF. The exact molecular
structure of mtDNA replication-termination intermediates is
unclear, although it cannot simply comprise two oppositely
moving forks that have almost met, since such a structure
would be thermally unstable unless the unreplicated region
between them were at least 50 bp, in which case they
would not lie precisely on the X-arc on 2DNAGE gels. One
possibility is that they are held together by hemicatenation
after ligation of at least one strand, although such forms
should be S1 nuclease-sensitive (53). Another is that they
are converted to true Holliday junctions. A third option is
that they contain a single or even double chicken-foot
structure.
Whatever their precise nature, a complex enzymatic
machinery should be required both to form and to resolve
them, in which TFAM is a plausible player, both because
of its DNA-binding preferences and bending properties and
by its putative ability to recruit other proteins to the DNA.
DNA-bending is required for the protein-based partition
systems of low copy-number bacterial plasmids such as P1
(54) and binding sites for the DNA-bending proteins H-NS
and FIS appear to be clustered around the replication
terminus in Escherichia coli (55). HMG and related proteins
are widely implicated as cofactors in recombination. For
example, mammalian HMGB1 facilitates V(D)J recombi-
nation by the RAG proteins (56). In bacteria, HU is essential
for efﬁcient homologous recombination (57) and IHF is
required for the action of lambda integrase (58). HMG
proteins are able to facilitate recombination even in hetero-
logous systems [see Ref. (59)]. In yeast mitochondria,
overexpression of Abf2p promotes the formation of recombi-
nation intermediates (60). DNA-bending by TFAM may
facilitate analogous processes in human mtDNA.
A rather different interpretation would also be consistent
with the 2DNAGE data, namely that TFAM overexpression
leads to a high frequency of strand breakage at OH. This
would account both for the relative paucity of bubble arcs
in OH-containing fragments, (Figure 2b and c), for the
corresponding increase in simple Y arcs and for the loss of
termination intermediates (Figures 2c, and 3b). Such strand-
breakage is very unlikely to be an extraction artefact, since
these differences from control cells were seen in all of the
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correct, it may imply a need for true recombination reaction
to resolve daughter molecules, which could be much slower
than the usual termination/resolution step. Copy number
depletion might therefore be due to interference with termina-
tion when TFAM is either overexpressed or downregulated.
In addition, TFAM overexpression resulted in apparent
decatenation of mtDNA, whereas TFAM knockdown increa-
sed the level of linear molecules and of one decatenated
species that could also be generated in control cell mtDNA
by treatment with T7 gp3 endonuclease, a promiscuous
junctional resolvase. It is tempting to suggest that these
species may be aberrant breakdown products resulting from
failure of the normal termination step under conditions of
TFAM deﬁciency. The loss of catenated species in favour
of monomeric supercoils under conditions of TFAM over-
expression may again reﬂect the altered kinetics of mtDNA
replication, since it too was brought about by ddC treatment.
Alternatively an overcompacted state of mtDNA resulting
from excess TFAM may directly prevent catenation or
stimulate decatenation, as is known for the E.coli HU protein
acting on circular plasmid molecules (61). Decatenation
might also result from frequent strand-breakage at OH.
Under conditions of decreased copy number, decatenation
should be important for dispersal of newly replicated
mtDNAs into nucleoids, to restrain mitotic segregation of
possibly deleterious mtDNA sequence variants. In yeast, the
TFAM homologue Abf2p is required for efﬁcient parsing of
mtDNA into nucleoids (62), although this process appears to
involve recombination rather than decatenation.
Physiological role of TFAM as a mtDNA
copy number regulator
Our ﬁndings indicate that, at least in this particular proli-
ferating cell background, TFAM expression is ﬁnely poised.
Any marked deviations from what appears to be an optimal
expression level provoke alterations to mtDNA replication
that result in decreased mtDNA levels.
Previous studies of the transcriptional regulation of
the TFAM gene indicate that it is sensitive to signals
connected with metabolite supply (63) and redox stress, via
the phosphorylation of NRF-1 (64) and to proliferative,
differentiation-linked and environmental signals via the
co-activators PGC1 and PRC (65–67) and the transcription
factor Myc (68). This raises the issue of whether there is an
additional homeostatic, mechanism to ﬁne-tune TFAM
expression to the physical state of mtDNA, which can be
circumvented by the manipulations we carried out. A retro-
grade signalling pathway of this type might serve to ensure
that disturbances in mtDNA replication or segregation
do not lead to a copy number catastrophe. Alternatively,
the level of TFAM expression and possibly also its post-
translational modiﬁcation (69), may function in vivo to accel-
erate or decelerate mtDNA replication, thus constituting a
key determinant of copy number.
ACKNOWLEDGEMENTS
We thank Outi Kurronen and Merja Jokela for technical
assistance, Takehiro Yasukawa, Aurelio Reyes, Gertjan
Hakkaart, Anu Suomalainen (Wartiovaara) and colleagues
for constant advice and critical input and Rudi Wiesner
for supplying the anti-TFAM antibody. For financial
support of our research we are grateful to the Academy of
Finland, Juselius Foundation, Tampere University Hospital
Medical Research Fund, the University of Tampere, the EU
(EUMITOCOMBAT and MitEURO projects) and the UK
Medical Research Council. Funding to pay the Open Access
publication charges for this article was provided by the
foregoing organizations.
Conflict of interest statement. None declared.
REFERENCES
1. Clayton,D.A. (1982) Replication of animal mitochondrial DNA. Cell,
28, 693–705.
2. Yang,M.Y., Bowmaker,M., Reyes,A., Vergani,L., Angeli,P.,
Gringeri,E., Jacobs,H.T. and Holt,I.J. (2002) Biased incorporation of
ribonucleotides on the mitochondrial L-strand accounts for apparent
strand-asymmetric DNA replication. Cell, 111, 495–505.
3. Yasukawa,T., Yang,M.Y., Jacobs,H.T. and Holt,I.J. (2005) A
bidirectional origin of replication maps to the major noncoding region
of human mitochondrial DNA. Mol. Cell., 18, 651–662.
4. Holt,I.J., Lorimer,H.E. and Jacobs,H.T. (2000) Coupled leading- and
lagging-strand synthesis of mammalian mitochondrial DNA. Cell, 100,
515–524.
5. Bowmaker,M., Yang,M.Y., Yasukawa,T., Reyes,A., Jacobs,H.T.,
Huberman,J.A. and Holt,I.J. (2003) Mammalian mitochondrial DNA
replicates bidirectionally from an initiation zone. J. Biol. Chem., 278,
50961–50969.
6. Reyes,A., Yang,M.Y., Bowmaker,M. and Holt,I.J. (2005) Bidirectional
replication initiates at sites throughout the mitochondrial genome of
birds. J. Biol. Chem., 280, 3242–3250.
7. Kang,D. and Hamasaki,N. (2005) Mitochondrial transcription factor A
in the maintenance of mitochondrial DNA: overview of its multiple
roles. Ann. N Y Acad. Sci., 1042, 101–108.
8. Fisher,R.P. and Clayton,D.A. (1988) Purification and characterization
of human mitochondrial transcription factor 1. Mol. Cell. Biol., 8,
3496–3509.
9. Falkenberg,M., Gaspari,M., Rantanen,A., Trifunovic,A., Larsson,N.G.
and Gustafsson,C.M. (2002) Mitochondrial transcription factors B1 and
B2 activate transcription of human mtDNA. Nature Genet., 31,
289–294.
10. Larsson,N.G., Wang,J., Wilhelmsson,H., Oldfors,A., Rustin,P.,
Lewandoski,M., Barsh,G.S. and Clayton,D.A. (1998) Mitochondrial
transcription factor A is necessary for mtDNA maintenance and
embryogenesis in mice. Nature Genet., 18, 231–236.
11. Alam,T.I., Kanki,T., Muta,T., Ukaji,K., Abe,Y., Nakayama,H.,
Takio,K., Hamasaki,N. and Kang,D. (2003) Human mitochondrial
DNA is packaged with TFAM. Nucleic Acids Res., 31, 1640–1645.
12. Garrido,N., Griparic,L., Jokitalo,E., Wartiovaara,J., van der Bliek,A.M.
and Spelbrink,J.N. (2003) Composition and dynamics of human
mitochondrial nucleoids. Mol. Biol. Cell, 14, 1583–1596.
13. Fisher,R.P., Lisowsky,T., Breen,G.A. and Clayton,D.A. (1991) A rapid,
efficient method for purifying DNA-binding proteins.
Denaturation-renaturation chromatography of human and yeast
mitochondrial extracts. J. Biol. Chem., 266, 9153–9160.
14. Kanki,T., Ohgaki,K., Gaspari,M., Gustafsson,C.M., Fukuoh,A.,
Sasaki,N., Hamasaki,N. and Kang,D. (2004) Architectural role of
mitochondrial transcription factor A in maintenance of human
mitochondrial DNA. Mol. Cell. Biol., 24, 9823–9234.
15. Friddle,R.W., Klare,J.E., Martin,S.S., Corzett,M., Balhorn,R.,
Baldwin,E.P., Baskin,R.J. and Noy,A. (2004) Mechanism of DNA
compaction by yeast mitochondrial protein Abf2p. Biophys. J., 86,
1632–1639.
16. Diffley,J.F. and Stillman,B. (1991) A close relative of the nuclear,
chromosomal high-mobility group protein HMG1 in yeast
mitochondria. Proc. Natl Acad. Sci. USA, 88, 7864–7868.
17. Ohno,T., Umeda,S., Hamasaki,N. and Kang,D. (2000) Binding human
mitochondrial transcription factor A, an HMG box protein, to a
5826 Nucleic Acids Research, 2006, Vol. 34, No. 20four-way DNA junction. Biochem. Biophys. Res. Commun., 271,
492–498.
18. Yoshida,Y., Izumi,H., Ise,T., Uramoto,H., Torigoe,T., Ishiguchi,H.,
Murakami,T., Tanabe,M., Nakayama,Y., Itoh,H. et al. (2002) Human
mitochondrial transcription factor A binds preferentially to oxidatively
damaged DNA. Biochem. Biophys. Res. Commun., 295, 945–951.
19. Takamatsu,C., Umeda,S., Ohsato,T., Ohno,T., Abe,Y., Fukuoh,A.,
Shinagawa,H., Hamasaki,N. and Kang,D. (2002) Regulation of
mitochondrial D-loops by transcription factor A and single-stranded
DNA-binding protein. EMBO Rep., 3, 451–456.
20. Yoshida,Y., Izumi,H., Torigoe,T., Ishiguchi,H., Itoh,H., Kang,D. and
Kohno,K. (2003) P53 physically interacts with mitochondrial
transcription factor A and differentially regulates binding to damaged
DNA. Cancer Res., 63, 3729–3734.
21. Noack,H., Bednarek,T., Heidler,J., Ladig,R., Holtz,J. and Szibor,M.
(2006) TFAM-dependent and independent dynamics of mtDNA levels
in C2C12 myoblasts caused by redox stress. Biochim. Biophys. Acta,
1760, 141–150.
22. Ikeuchi,M., Matsusaka,H., Kang,D., Matsushima,S., Ide,T., Kubota,T.,
Fujiwara,T., Hamasaki,N., Takeshita,A., Sunagawa,K. et al. (2005)
Overexpression of mitochondrial transcription factor a ameliorates
mitochondrial deficiencies and cardiac failure after myocardial
infarction. Circulation, 112, 683–690.
23. Zelenaya-Troitskaya,O., Newman,S.M., Okamoto,K., Perlman,P.S. and
Butow,R.A. (1998) Functions of the high mobility group protein,
Abf2p, in mitochondrial DNA segregation, recombination and copy
number in Saccharomyces cerevisiae. Genetics, 148, 1763–1776.
24. O’Rourke,T.W., Doudican,N.A., Mackereth,M.D., Doetsch,P.W. and
Shadel,G.S. (2002) Mitochondrial dysfunction due to oxidative
mitochondrial DNA damage is reduced through cooperative actions of
diverse proteins. Mol. Cell. Biol., 22, 4086–4093.
25. Garstka,H.L., Schmitt,W.E., Schultz,J., Sogl,B., Silakowski,B.,
Perez-Martos,A., Montoya,J. and Wiesner,R.J. (2003) Import of
mitochondrial transcription factor A (TFAM) into rat liver
mitochondria stimulates transcription of mitochondrial DNA. Nucleic
Acids Res., 31, 5039–5047.
26. Gensler,S., Weber,K., Schmitt,W.E., Perez-Martos,A., Enriquez,J.A.,
Montoya,J. and Wiesner,R.J. (2001) Mechanism of mammalian
mitochondrial DNA replication: import of mitochondrial transcription
factor A into isolated mitochondria stimulates 7S DNA synthesis.
Nucleic Acids Res., 29, 3657–3663.
27. Maniura-Weber,K., Goffart,S., Garstka,H.L., Montoya,J. and
Wiesner,R.J. (2004) Transient overexpression of mitochondrial
transcription factor A (TFAM) is sufficient to stimulate mitochondrial
DNA transcription, but not sufficient to increase mtDNA copy number
in cultured cells. Nucleic Acids Res., 32, 6015–6027.
28. Parisi,M.A., Xu,B. and Clayton,D.A. (1993) A human mitochondrial
transcriptional activator can functionally replace a yeast mitochondrial
HMG-box protein both in vivo and in vitro. Mol. Cell. Biol., 13,
1951–1961.
29. Dairaghi,D.J., Shadel,G.S. and Clayton,D.A. (1995) Addition of a 29
residue carboxyl-terminal tail converts a simple HMG box-containing
protein into a transcriptional activator. J. Mol. Biol., 249, 11–28.
30. Matsushima,Y., Matsumura,K., Ishii,S., Inagaki,H., Suzuki,T.,
Matsuda,Y., Beck,K. and Kitagawa,Y. (2003) Functional domains of
chicken mitochondrial transcription factor A for the maintenance of
mitochondrial DNA copy number in lymphoma cell line DT40.
J. Biol. Chem., 278, 31149–31158.
31. Ekstrand,M.I., Falkenberg,M., Rantanen,A., Park,C.B., Gaspari,M.,
Hultenby,K., Rustin,P., Gustafsson,C.M. and Larsson,N.G. (2004)
Mitochondrial transcription factor A regulates mtDNA copy number in
mammals. Hum. Mol. Genet., 13, 935–944.
32. Seidel-Rogol,B.L. and Shadel,G.S (2002) Modulation of mitochondrial
transcription in response to mtDNA depletion and repletion in HeLa
cells. Nucleic Acids Res., 30, 1929–1934.
33. Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning.
A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY.
34. Lehtinen,S.K., Hance,N., El Meziane,A., Juhola,M.K., Juhola,K.M.,
Karhu,R., Spelbrink,J.N., Holt,I.J. and Jacobs,H.T. (2000) Genotypic
stability, segregation and selection in heteroplasmic human cell lines
containing np 3243 mutant mtDNA. Genetics, 154, 363–380.
35. Tyynismaa,H., Sembongi,H., Bokori-Brown,M., Granycome,C.,
Ashley,N., Poulton,J., Jalanko,A., Spelbrink,J.N., Holt,I.J. and
Suomalainen,A. (2004) Twinkle helicase is essential for mtDNA
maintenance and regulates mtDNA copy number. Hum. Mol. Genet.,
13, 3219–3227.
36. El Meziane,A, Lehtinen,S.K., Hance,N., Nijtmans,L.G., Dunbar,D.G.,
Holt,I.J. and Jacobs,H.T. (1998) A tRNA suppressor mutation in human
mitochondria. Nature Genet., 18, 350–353.
37. Toompuu,M., Yasukawa,T., Suzuki,T., Hakkinen,T., Spelbrink,J.N.,
Watanabe,K. and Jacobs,H.T. (2002) The 7472insC mitochondrial
DNA mutation impairs the synthesis and extent of aminoacylation of
tRNASer(UCN) but not its structure or rate of turnover. J. Biol. Chem.,
277, 22240–22250.
38. Spelbrink,J.N., Toivonen,J.M., Hakkaart,G.A., Kurkela,J.M.,
Cooper,H.M., Lehtinen,S.K., Lecrenier,N., Back,J.W., Speijer,D.,
Foury,F. et al. (2000) In vivo functional analysis of the human
mitochondrial DNA polymerase POLG expressed in cultured human
cells. J. Biol. Chem., 275, 24818–24828.
39. Kajander,O.A., Karhunen,P.J., Holt,I.J. and Jacobs,H.T. (2001)
Prominent mitochondrial DNA recombination intermediates in human
heart muscle. EMBO Rep., 2, 1007–1012.
40. Brown,T.A. and Clayton,D.A. (2002) Release of replication
termination controls mitochondrial DNA copy number after depletion
with 20,30-dideoxycytidine. Nucleic Acids Res., 30, 2004–2010.
41. Ghivizzani,S.C., Madsen,C.S. and Hauswirth,W.W. (1993) In
organello footprinting. Analysis of protein binding at regulatory
regions in bovine mitochondrial DNA. J. Biol. Chem., 268,
8675–8682.
42. Ghivizzani,S.C., Madsen,C.S., Nelen,M.R., Ammini,C.V. and
Hauswirth,W.W. (1994) In organello footprint analysis of human
mitochondrial DNA: human mitochondrial transcription factor A
interactions at the origin of replication. Mol. Cell. Biol., 14,
7717–7730.
43. Cantatore,P., Daddabbo,L., Fracasso,F. and Gadaleta,M.N. (1995)
Identification by in organello footprinting of protein contact sites and
of single-stranded DNA sequences in the regulatory region of rat
mitochondrial DNA. Protein binding sites and single-stranded DNA
regions in isolated rat liver mitochondria. J. Biol. Chem., 270,
25020–25027.
44. Micol,V., Fernandez-Silva,P. and Attardi,G. (1997) Functional analysis
of in vivo and in organello footprinting of HeLa cell mitochondrial
DNA in relationship to ATP and ethidium bromide effects on
transcription. J. Biol. Chem., 272, 18896–18904.
45. Abhyankar,M.M., Zzaman,S. and Bastia,D. (2003) Reconstitution
of R6K DNA replication in vitro using 22 purified proteins.
J. Biol. Chem., 278, 45476–45484.
46. Wissmuller,S., Kosian,T., Wolf,M., Finzsch,M. and Wegner,M. (2006)
The high-mobility-group domain of Sox proteins interacts with
DNA-binding domains of many transcription factors. Nucleic Acids
Res., 34, 1735–1744.
47. McCulloch,V. and Shadel,G.S. (2003) Human mitochondrial
transcription factor B1 interacts with the C-terminal activation region
of h-mtTFA and stimulates transcription independently of its RNA
methyltransferase activity. Mol. Cell. Biol., 23, 5816–5824.
48. Mayhook,A.G., Rinaldi,A.M. and Jacobs,H.T. (1992) Replication
origins and pause sites in sea urchin mitochondrial DNA.
Proc. Biol. Sci., 248, 85–94.
49. Brewer,B.J., Lockshon,D. and Fangman,W.L. (1992) The arrest of
replication forks in the rDNA of yeast occurs independently of
transcription. Cell, 71, 267–276.
50. Mirkin,E.V. and Mirkin,S.M. (2005) Mechanisms of
transcription-replication collisions in bacteria. Mol. Cell. Biol., 25,
888–895.
51. French,S. (1992) Consequences of replication fork movement trough
transcription units in vivo. Science, 258, 1362–1365.
52. Krings,G. and Bastia,D. (2005) Sap1p binds to Ter1 at the ribosomal
DNA of Schizosaccharomyces pombe and causes polar replication fork
arrest. J. Biol. Chem., 280, 39135–39142.
53. Liberi,G., Maffioletti,G., Lucca,C., Chiolo,I., Baryshnikova,A.,
Cotta-Ramusino,C., Lopes,M., Pellicioli,A., Haber,J.E. et al. (2005)
Rad51-dependent DNA structures accumulate at damaged replication
forks in sgs1 mutants defective in the yeast orthologue of BLM RecQ
helicase. Genes Dev., 19, 339–350.
54. Funnell,B.E. (1988) Participation of Escherichia coli integration host
factor in the P1 plasmid partition system. Proc. Natl Acad. Sci. USA,
85, 6657–6661.
Nucleic Acids Research, 2006, Vol. 34, No. 20 582755. Ussery,D., Larsen,T.S, Wilkes,K.T., Friis,C., Worning,P., Krogh,A.
and Brunak,S. (2001) Genome organisation and chromatin structure in
Escherichia coli. Biochimie, 83, 201–212.
56. van Gent,D.C., Hiom,K., Paull,T.T. and Gellert,M. (1997) Stimulation
of V(D)J cleavage by high mobility group proteins. EMBO J., 16,
2665–2670.
57. Li,S. and Waters,R. (1998) Escherichia coli strains lacking HU are UV
sensitive due to a role for HU in homologous recombination.
J. Bacteriol., 180, 3750–3756.
58. Moitoso de Vargas,L., Kim,S. and Landy,A. (1989) DNA looping
generated by DNA bending protein IHF and the two domains of lambda
integrase. Science, 244, 1457–1461.
59. Stemmer,C., Fernandez,S., Lopez,G., Alonso,J.C. and Grasser,K.D.
(2002) Plant chromosomal HMGB proteins efficiently promote the
bacterial site-specific beta-mediated recombination in vitro and in vivo.
Biochemistry, 41, 7763–7770.
60. MacAlpine,D.M., Perlman,P.S. and Butow,R.A. (1998) The high
mobility group protein Abf2p influences the level of yeast
mitochondrial DNA recombination intermediates in vivo. Proc. Natl
Acad. Sci. USA, 95, 6739–6743.
61. Marians,K.J. (1987) DNA gyrase-catalyzed decatenation of multiply
linked DNA dimers. J. Biol. Chem., 262, 10362–10368.
62. MacAlpine,D.M., Perlman,P.S. and Butow,R.A. (2000) The numbers of
individual mitochondrial DNA molecules and mitochondrial DNA
nucleoids in yeast are co-regulated by the general amino acid control
pathway. EMBO J., 19, 767–775.
63. Choi,Y.S., Lee,K.U. and Pak,Y.K. (2004) Regulation of mitochondrial
transcription factor A expression by high glucose. Ann. NY Acad. Sci.,
1011, 69–77.
64. Piantadosi,C.A. and Suliman,H.B. (2006) Mitochondrial transcription
factor A induction by redox activation of nuclear respiratory factor 1.
J. Biol. Chem., 281, 324–333.
65. Irrcher,I., Adhihetty,P.J., Sheehan,T., Joseph,A.M. and Hood,D.A.
(2003) PPARgamma coactivator-1alpha expression during thyroid
hormone- and contractile activity-induced mitochondrial adaptations.
Am. J. Physiol. Cell Physiol., 284, C1669–C1677.
66. Andersson,U. and Scarpulla,R.C. (2001) Pgc-1-related coactivator, a
novel, serum-inducible coactivator of nuclear respiratory factor
1-dependent transcription in mammalian cells. Mol. Cell. Biol., 21,
3738–3749.
67. Wu,Z., Puigserver,P., Andersson,U., Zhang,C., Adelmant,G.,
Mootha,V., Troy,A., Cinti,S., Lowell,B., Scarpulla,R.C. et al. (1999)
Mechanisms controlling mitochondrial biogenesis and respiration
through the thermogenic coactivator PGC-1. Cell, 98, 115–124.
68. Li,F., Wang,Y., Zeller,K.I., Potter,J.J., Wonsey,D.R., O’Donnell,K.A.,
Kim,J.W., Yustein,J.T., Lee,L.A. and Dang,C.V. (2005) Myc
stimulates nuclearly encoded mitochondrial genes and mitochondrial
biogenesis. Mol. Cell. Biol., 25, 6225–6234.
69. Dinardo,M.M., Musicco,C., Fracasso,F., Milella,F., Gadaleta,M.N.,
Gadaleta,G. and Cantatore,P. (2003) Acetylation and level of
mitochondrial transcription factor A in several organs of young and old
rats. Biochem. Biophys. Res. Commun., 301, 187–191.
5828 Nucleic Acids Research, 2006, Vol. 34, No. 20